Lennox-Gastaut Syndrome Reference¶
Historical Context and Treatment Evolution¶
Early Clinical Recognition (1930s-1950s)¶
The syndrome that would eventually bear his name was first described by American neurologist William Gordon Lennox of Boston. In the 1930s, Lennox identified the clinical features of a distinct childhood epilepsy pattern, and in 1950, he and Davis published the first comprehensive description of the symptomatic triad: multiple seizure types, cognitive impairment, and a distinctive slow spike-and-wave EEG pattern.
Lennox's work established that this was not simply "severe epilepsy" but a specific syndrome with predictable features and devastating prognosis. At the time, treatment options were limited to phenobarbital and bromides—medications that provided minimal seizure control and significant cognitive side effects for these patients.
Gastaut's Comprehensive Description (1966)¶
The document that Henri Gastaut and colleagues published in Epilepsia in 1966 transformed understanding of the syndrome. Gastaut's team at the Marseille school provided comprehensive clinical and electroencephalographic characterization, describing LGS as a severe form of childhood epilepsy that was refractory to the antiepileptic treatments then available.
They documented the hallmark features: frequent generalized epileptic seizures—most commonly tonic or absence seizures—and specific EEG patterns consisting of interictal discharges of diffuse slow spike-waves repeated at 1.5 to 2.5 cycles per second. This precise characterization allowed clinicians worldwide to recognize and diagnose the syndrome consistently.
At the second meeting dedicated to this concept, held in Marseille in September 1966, Margaret Lennox-Buchthal—William Lennox's daughter—suggested the syndrome be named "Lennox-Gastaut Syndrome" in honor of both her father's initial description and the Marseille school's confirmation and completion of the clinical picture.
The Era of Limited Treatment Options (1966-1990s)¶
For decades after the syndrome's formal description, treatment remained frustratingly inadequate. The antiepileptic medications available—phenobarbital, phenytoin, carbamazepine—were developed for focal epilepsies and often failed to control the multiple seizure types characteristic of LGS. Patients continued to experience frequent breakthrough seizures despite maximum tolerated doses, while medication side effects including sedation and cognitive dulling compounded the developmental challenges already present.
Clonazepam became the first medication specifically FDA-approved for LGS in 1975, offering some additional control particularly for myoclonic and absence seizures. However, tolerance often developed over time, and the benzodiazepine's sedating effects limited its utility.
Valproate, introduced in the 1970s, became a cornerstone of LGS treatment—considered first-line therapy due to its broad-spectrum activity against multiple seizure types. However, it too failed to provide complete seizure control for most patients and carried risks including liver toxicity, particularly in young children.
Expanded Pharmacological Options (1990s-2000s)¶
The 1990s brought new medications that expanded treatment options:
Felbamate (1993) demonstrated effectiveness for LGS but carried serious risks of aplastic anemia and liver failure that limited its use to refractory cases under careful monitoring.
Lamotrigine (1998) showed effectiveness in reducing seizures and gained FDA approval, offering a better-tolerated option for many patients.
Topiramate (2001) trials demonstrated significant seizure reduction, leading to FDA approval for adjunctive treatment.
Rufinamide (2008) was approved specifically for LGS-associated seizures in children 4 years and older.
Clobazam (2011) provided another benzodiazepine option with perhaps less sedation than clonazepam.
Despite these advances, LGS remained treatment-resistant by definition. Multiple medications typically achieved incomplete control at best. Families cycled through drug combinations, accepting partial seizure reduction while managing cumulative side effects.
The Cannabidiol Era (2018)¶
The FDA approval of cannabidiol (Epidiolex) in 2018 represented a landmark moment—the first cannabis-derived medication approved for seizure treatment in the United States. Clinical trials demonstrated significant seizure reduction in LGS patients, and the medication offered a new mechanism of action for patients who had failed traditional antiepileptic drugs.
The approval followed years of patient advocacy, with families of children with severe epilepsy pushing for access to cannabis-based treatments they observed providing benefit. The path from parental observation to FDA approval demonstrated the power of patient communities to influence medical research priorities.
Fenfluramine (2022) added another option, the most recent FDA-approved medication for LGS.
Non-Pharmacological Approaches¶
Recognizing that medications alone rarely achieve adequate control, treatment expanded to include:
Ketogenic diet, a high-fat, low-carbohydrate dietary protocol that can reduce seizure frequency in some patients—first described for epilepsy in the 1920s but remaining relevant for treatment-resistant cases.
Vagus nerve stimulation (VNS), surgically implanted devices that deliver electrical impulses to reduce seizure frequency.
Corpus callosotomy, surgical severing of connections between brain hemispheres to prevent generalized seizures—particularly effective for reducing drop attacks.
Deep brain stimulation and responsive neurostimulation, newer neuromodulation approaches offering additional options for refractory patients.
Era-Specific Implications for Affected Characters¶
Minjae Lee (born 2015, LGS diagnosed in early childhood) experiences his epilepsy in an era of expanded treatment options unimaginable to patients in Lennox's time. He has access to eight FDA-approved medications including cannabidiol, multiple antiepileptic drugs in combination, VNS technology, and specialized epilepsy programs at institutions like Johns Hopkins.
Yet these advances haven't eliminated his seizures. His treatment-resistant LGS continues to manifest with multiple daily seizure types, breakthrough events despite polytherapy, and the constant danger of drop seizures requiring his specialized wheelchair with safety harness. The 2032 family relocation from China to Baltimore for access to Johns Hopkins' epilepsy program demonstrates that even in an era of multiple treatment options, specialized expertise remains geographically concentrated.
Minjae's health crash following the Rome International Piano Competition—multiple seizures during sleep, barely opening his eyes for days, his mother considering hospitalization—illustrates that even state-of-the-art treatment cannot prevent the severe consequences of pushing physical limits. Modern medicine manages LGS; it does not cure it.
Caleb Ross shares the LGS diagnosis but demonstrates the syndrome's variable presentation. His experience validates that LGS is not a single illness but a spectrum of manifestations requiring individualized treatment approaches.
Overview¶
Lennox-Gastaut Syndrome (LGS) is a severe and complex form of epilepsy that typically begins in childhood and is characterized by multiple types of seizures, intellectual disability or developmental delays, and a distinctive slow spike-and-wave pattern on EEG. Unlike more common forms of epilepsy, LGS involves several different seizure types occurring in the same individual, making treatment particularly challenging and often requiring multiple medications simultaneously.
The condition manifests with tonic seizures (sudden muscle stiffening), atonic seizures (sudden loss of muscle tone, often called "drop seizures"), absence seizures (brief lapses in awareness), tonic-clonic seizures (convulsive seizures), and focal seizures (affecting one part of the brain). The variety and unpredictability of seizure types creates constant danger and requires intensive medical management and safety precautions.
LGS is notoriously treatment-resistant, with many individuals continuing to experience breakthrough seizures despite appropriate medication. The condition typically causes or exacerbates cognitive delays and developmental challenges, though the degree varies among individuals. The syndrome often persists throughout life, though seizure patterns may evolve over time. The unpredictable nature of seizures, combined with their frequency and severity, profoundly impacts every aspect of daily functioning and requires constant vigilance from both the individual and their caregivers.
Representation in Canon¶
Minjae Lee lives with Lennox-Gastaut Syndrome as one of his multiple complex conditions, including cerebral palsy, autism, POTS, gastroparesis, and likely Chronic Fatigue Syndrome. His LGS represents his most life-threatening condition, creating constant seizure risk that shaped his family's decision to relocate internationally for better medical care. Born October 1, 2015, his syndrome was diagnosed in early childhood, though the exact timing remains to be documented.
Minjae experiences the full range of LGS seizure types. His absence seizures appear as brief periods where he "goes away"—his eyes might glaze over, his body becomes still, and he's temporarily unreachable. These can last seconds to minutes and may occur multiple times daily. His focal seizures affect specific parts of his body, causing twitching or altered sensation in his hands, face, or limbs. His tonic-clonic seizures involve full-body convulsions with loss of consciousness, requiring careful positioning to prevent injury and close monitoring during recovery periods.
Most dangerously, Minjae experiences frequent drop seizures where he suddenly loses all muscle tone without warning, causing him to collapse. These drop seizures necessitate his use of a specialized wheelchair with a full five-point harness system that prevents him from falling forward or sideways when seizures occur. Without this harness, drop seizures would cause repeated head injuries and make mobility catastrophically dangerous. The unpredictability of drop seizures means he cannot safely navigate spaces without his wheelchair, even if his cerebral palsy alone might allow short-distance walking with support.
He has also experienced status epilepticus—prolonged seizures or seizure clusters that don't stop on their own—representing medical emergencies requiring immediate intervention. His family is trained in emergency seizure protocols, including when to administer rescue medications and when to call emergency services.
His seizure frequency fluctuates based on stress, illness, fatigue, hormonal changes, and other factors that aren't always predictable or controllable. Following the Rome International Piano Competition in 2032, his seizure activity increased dramatically, with multiple seizures occurring during sleep and his overall health crashing so severely that his mother considered hospitalization. This pattern—where physical or emotional stress triggers worsening seizure activity—represents the fragile balance he must maintain.
Minjae's LGS intersects with his other conditions in complex ways. His POTS and Chronic Fatigue Syndrome mean he has less physical reserve to recover from seizures. His cerebral palsy affects his ability to catch himself or protect his head during seizures. His autism and moderate global developmental delays mean he cannot always communicate when he feels a seizure coming or articulate how he feels post-seizure. His gastroparesis complicates medication management, as nausea and delayed gastric emptying affect medication absorption.
Caleb Ross also lives with Lennox-Gastaut Syndrome alongside hypotonic cerebral palsy and other complex conditions. His LGS presents differently than Minjae's, demonstrating how the same syndrome manifests uniquely across individuals. The shared diagnosis creates profound mutual understanding between the two boys—when one experiences a seizure, the other recognizes what's happening because it happens to him too, creating continuity and calm rather than panic. Their friendship is partially built on this shared reality of living with bodies that can betray them without warning.
Daily Impact and Management¶
Living with Lennox-Gastaut Syndrome means every day involves balancing medication schedules, monitoring for seizure activity, and maintaining safety protocols while trying to preserve quality of life and autonomy. For Minjae, this balance shapes every aspect of his existence.
His medication regimen involves multiple anti-seizure drugs (antiepileptic drugs or AEDs) taken on precise schedules throughout the day. These medications must be timed relative to meals due to his gastroparesis, creating complex coordination between seizure management and digestive management. His family maintains detailed medication logs tracking doses, timing, any missed doses due to vomiting, and breakthrough seizure activity. When medications are adjusted—dosage changes or new drugs added—the family watches carefully for both therapeutic effects and side effects, knowing that side effects often include cognitive dulling, fatigue, mood changes, nausea, dizziness, and other symptoms that overlap with his existing conditions.
Despite medication, breakthrough seizures remain common. His family recognizes the warning signs when he's approaching higher seizure risk—increased absence seizures, changes in sleep patterns, elevated stress or illness, hormonal fluctuations. During high-risk periods, they intensify monitoring, avoid triggers when possible, and prepare emergency medications.
His specialized wheelchair with full harness represents his primary safety equipment. The five-point harness system keeps him secured in position during drop seizures, preventing him from pitching forward onto his face or slumping sideways out of the chair. His family ensures the harness is properly adjusted but not uncomfortably tight, balancing safety with his sensory sensitivities and comfort. The wheelchair also provides padding and positioning support that protects him during seizures that occur while seated.
Environmental modifications throughout his home prioritize seizure safety. Sharp corners are padded, dangerous areas are blocked off, and his bedroom is designed as a safe space where seizures won't cause injury. His bed likely has padded rails or is positioned to minimize fall risk. Bathroom modifications address the particular danger of seizures in wet, hard-surfaced spaces. His family never leaves him unattended in situations where a seizure could be catastrophic—bathing, elevated surfaces, near water, in public spaces without adequate supervision.
His daily schedule must account for post-seizure recovery periods. After tonic-clonic or prolonged absence seizures, he needs rest time—his body and brain require recovery before he can safely engage in activities again. This recovery time is non-negotiable, not something he can "push through," and his family has learned to build flexibility into schedules to accommodate these unpredictable pauses.
Sleep management intersects significantly with seizure control. Many of his seizures occur during sleep, and poor sleep quality increases daytime seizure risk. His family monitors his sleep patterns, recognizing that clusters of nighttime seizures often signal worsening control that requires medical intervention. The Chronic Fatigue Syndrome complicated by frequent seizures creates a vicious cycle—fatigue increases seizure risk, seizures increase fatigue.
Activity limitations necessarily shape his life. Physical exertion can trigger seizures, as can overheating, dehydration, and exhaustion. His participation in activities like the Rome International Piano Competition required careful planning—shorter practice sessions, frequent breaks, careful attention to hydration and temperature, and acceptance that the physical toll might cause post-event seizure increases. His family makes these calculations constantly: which experiences are worth the increased seizure risk, and which pose unacceptable danger.
Sensory and Environmental Considerations¶
Environmental factors significantly influence seizure activity in Lennox-Gastaut Syndrome, requiring careful management of sensory inputs and physical conditions.
Flashing or flickering lights can trigger photosensitive seizures in some individuals with epilepsy, making spaces with fluorescent lighting, strobe effects, or rapidly changing visual patterns dangerous. When Minjae attempted day programs, fluorescent institutional lighting contributed to his sensory overwhelm and may have increased seizure risk. His family maintains consistent, gentle lighting in their home—avoiding harsh overhead lights in favor of lamps with warm, steady illumination.
Temperature extremes affect seizure thresholds. Overheating particularly increases seizure risk, meaning hot weather, overheated indoor spaces, and physical exertion that raises body temperature all require monitoring and management. During the Rome competition, the practice hall's warmth made Minjae's joints feel looser but his eyelids heavier—the heat creating both physical effects and increasing his seizure risk. His family ensures he has access to cooling strategies, appropriate clothing, and rest periods to prevent dangerous temperature elevation.
Noise and sensory overwhelm contribute to seizure risk, particularly for individuals like Minjae whose autism creates sensory processing challenges. Loud, chaotic environments with multiple competing stimuli tax his nervous system in ways that lower his seizure threshold. The institutional day program's loud television and chaotic atmosphere likely increased his seizure risk alongside his autistic sensory distress. His family creates calm, predictable sensory environments that minimize this compounding stress.
Sleep deprivation and disrupted sleep dramatically increase seizure activity. Maintaining consistent sleep schedules and sleep hygiene practices is essential, though difficult when nighttime seizures themselves disrupt sleep. His family must balance the need for consistent sleep against the reality that his body doesn't always cooperate.
Stress—emotional, physical, cognitive—lowers seizure thresholds. Major life changes like international relocation, significant events like performing in competitions, relationship stress, family tension, even positive excitement can all trigger increased seizure activity. This reality means his family must carefully manage his exposure to stressful situations, preparing him for changes when possible and providing support to minimize stress responses.
Illness dramatically increases seizure activity. Fever, infections, gastrointestinal illness, and other physical stresses often precipitate seizure clusters. His gastroparesis and overall medical fragility mean he's more vulnerable to illness than his peers, creating higher seizure risk.
Emotional and Psychological Context¶
Living with Lennox-Gastaut Syndrome profoundly impacts emotional and psychological wellbeing, creating layers of fear, grief, frustration, and resilience that shape daily experience.
For Minjae, the unpredictability of seizures creates sustained anxiety. His body can betray him without warning—during meals, while playing music, in the middle of conversations, during sleep. This unpredictability means he can never feel completely safe, never fully relax into activities without some awareness that a seizure might interrupt. His high anxiety and emotional sensitivity likely connect to this constant uncertainty, his nervous system unable to achieve the baseline calm that bodies without life-threatening conditions can maintain.
The loss of consciousness during many seizure types creates particular fear. Tonic-clonic seizures rob him of awareness and control, leaving gaps in his memory where time simply disappears. Coming back from these seizures means reorienting to surroundings, processing that time has passed, dealing with the exhaustion and confusion that follow. For someone whose communication is already limited, this additional disruption to consciousness and cognition makes the world feel even less comprehensible and controllable.
The physical pain and exhaustion from seizures accumulates over time. Each tonic-clonic seizure is essentially a full-body workout where every muscle contracts intensely—the aftermath feels like having been beaten up, with muscle soreness, fatigue, and sometimes injuries from falls or contortions. Drop seizures may not hurt during the event, but the accumulation of minor injuries over years of sudden collapses creates chronic physical discomfort. This sustained pain and exhaustion shapes mood, capacity for engagement, and overall quality of life.
His moderate global developmental delays mean he may not fully understand his condition in medical terms, but he absolutely understands the experience—the fear before seizures, the disorientation after, the way adults' faces change when he seizes, the interventions and restrictions imposed for his safety. He experiences the loss of autonomy even if he can't articulate it in complex language. His extremely trusting nature and his fear of being a burden likely connect to his awareness that his seizures create stress and work for his family.
For his family, particularly his mother Nari, the sustained terror of watching their child seize never fully dissipates. Even as they've learned to respond calmly during seizures, to position him properly and time the duration and administer medications, the underlying horror of watching your child's brain misfire and their body convulse or collapse remains. Nari's role as his "safe harbor" includes absorbing and managing this terror so he doesn't have to carry her fear alongside his own.
The grief of what LGS takes from him pervades family life. He cannot safely be left alone, cannot drive, cannot participate in many activities his peers enjoy, faces educational and social limitations not just from his developmental delays but from the very real danger his seizures create. His musical talent demonstrated at Rome showed what he could achieve—and also showed how much his conditions cost him, the health crash afterward illustrating the price of pushing his limits.
The social isolation that epilepsy creates compounds his existing communication and social challenges. Many people feel uncomfortable around seizures, unsure how to respond or frightened by the visible manifestation of neurological dysfunction. Some avoid him to avoid witnessing seizures, or treat him with excessive caution that diminishes his dignity. The seizures become another barrier to social connection in a life already marked by communication differences and disability.
Yet Minjae demonstrates remarkable resilience. He continues to engage with music, maintains loving relationships, expresses joy and affection, pursues the life he wants within his constraints. His engagement represents not denial of his condition but integration of it—he is a person who experiences seizures, not a seizure disorder that happens to inhabit a body. This integration, supported by family who see his full personhood, allows him to build meaningful life despite extraordinary challenges.
Notable Events or Arcs¶
Rome International Piano Competition (2032): Minjae's participation in this prestigious competition demonstrated both his remarkable musical talent and the physical toll his conditions exact. During the competition week, he managed seizure risk while performing at an elite level, pushing his body to limits that would later exact terrible cost. Following the family's return to Tianjin, he experienced severe health crash with multiple seizures during sleep, barely opening his eyes for days, and his mother considering hospitalization. The increased seizure activity persisted for weeks, compounded by the onset of atypical puberty. This event directly contributed to the family's decision to relocate to Baltimore for better medical management.
Failed Day Program Attempts (2033-2034): When Minjae's family sought community day programs for him, his seizure disorder complicated placement. The second program's staff dismissed his AAC communication that he needed to nap, telling him to "just finish" the activity first. Within minutes, he experienced what appeared to be a fatigue-induced crash, falling asleep slumped over the art table with his face nearly in paint, breathing rapid and shallow. His mother Nari returned to find him unconscious with blue paint in his hair. The program staff's failure to recognize this as medical crisis rather than "normal tiredness" demonstrated dangerous lack of seizure awareness. The director's lecture about "pushing through discomfort" revealed fundamental misunderstanding that for someone with LGS and CFS, ignoring physical limits creates genuine medical danger, not character growth.
Relocation to Baltimore for Medical Care (2032): The Lee family's decision to relocate from Tianjin, China to Baltimore, Maryland was driven significantly by inadequate seizure management available in China. Chinese doctors had essentially given up on improving Minjae's treatment, while American facilities at Johns Hopkins offered possibility of better seizure control and management of his complex multi-system presentation. The entire family uprooted their lives—leaving extended family, familiar healthcare providers, and cultural community—because his LGS and other conditions required specialized care unavailable in their home country.
Related Entries: Rome International Piano Competition - Event; Lee Family Relocation to United States - Event
Public and Cultural Perception¶
Within the Faultlines universe, Lennox-Gastaut Syndrome represents one of the more severe and widely recognized forms of childhood epilepsy, though public understanding remains limited. Many people have heard of epilepsy generally but don't understand the specific challenges of LGS—the multiple seizure types, the treatment resistance, the profound impact on development and daily functioning.
The visible nature of some seizure types, particularly tonic-clonic and drop seizures, means Minjae's condition is often immediately apparent to others. This visibility creates both positive and negative social consequences. Some people respond with appropriate concern and willingness to learn about accommodating his needs. Others respond with fear, discomfort, or patronizing pity that reduces him to his most dramatic symptoms rather than seeing his full personhood.
The CRATB community's integration of multiple disabled members, including those with seizure disorders, provides context where Minjae's epilepsy isn't sensationalized or hidden but simply acknowledged as part of who he is. Charlie Rivera and other disabled adults model treating seizures as medical events requiring appropriate response but not panic or dramatization. This normalization allows Minjae to exist more comfortably, his seizures recognized without becoming his defining feature.
Medical professionals' attitudes toward LGS vary significantly. Some providers understand the complexity and work collaboratively with families to maximize quality of life alongside seizure management. Others focus solely on seizure reduction numbers, dismissing family concerns about medication side effects or the impact of aggressive treatment on the child's overall functioning. The Lee family's experience navigating these different approaches—including the Chinese doctors who essentially gave up on treatment—demonstrates how provider attitudes profoundly affect outcomes and family wellbeing.
Accessibility Technology and Care Infrastructure¶
Managing Lennox-Gastaut Syndrome requires specialized equipment, medications, and support systems that shape daily life.
Specialized Wheelchair with Safety Harness: Minjae uses a wheelchair with a full five-point harness system specifically designed to prevent injury during drop seizures. This harness keeps him secured in position when he suddenly loses muscle tone, preventing him from pitching forward onto his face, slumping sideways out of the chair, or injuring his head and neck during unexpected collapses. The harness system must be properly adjusted to balance security with comfort and sensory tolerance, tight enough to provide safety but not so restrictive it causes distress. This adaptive equipment represents the intersection of his mobility needs (from cerebral palsy) and seizure safety needs (from LGS), demonstrating how multiple conditions require integrated solutions rather than separate accommodations.
Anti-Epileptic Medications (AEDs): Minjae's medication regimen involves multiple AEDs taken on strict schedules throughout the day. These medications may include combinations of drugs like valproic acid, lamotrigine, topiramate, clobazam, rufinamide, cannabidiol, or other agents used specifically for LGS management. The specific medications and dosages require constant adjustment based on seizure activity, side effects, and changes in his body as he grows and develops. Medication management is complicated by his gastroparesis, which affects absorption, and his difficulty communicating side effects, which makes monitoring for adverse reactions more challenging.
Rescue Medications: His family maintains emergency seizure medications (likely rectal diazepam or intranasal midazolam) for use during prolonged seizures or status epilepticus. Family members are trained in when and how to administer these medications, how long to wait before calling emergency services, and how to position him safely during and after administration.
Medical Alert Identification: He wears medical alert jewelry or identification that communicates his seizure disorder, medication list, and emergency contact information. This identification is critical for ensuring appropriate emergency response if he seizes in public or when family members aren't immediately available to provide medical history.
Johns Hopkins Hospital Epilepsy Program: Following the family's relocation to Baltimore, Minjae receives care through Johns Hopkins Hospital's specialized epilepsy program. Access to neurologists with specific LGS expertise, epilepsy monitoring units for assessing seizure activity, and coordination with other specialists managing his multiple conditions provides comprehensive care unavailable in their previous location. The decision to relocate internationally specifically for access to this level of specialized care demonstrates how essential appropriate medical infrastructure is for managing complex epilepsy.
Home Safety Modifications: The Lee family home includes extensive modifications addressing seizure safety—padded corners and edges, safe bathroom setup addressing the danger of wet, hard surfaces, bedroom designed as safe space where seizures won't cause injury, removal or securing of dangerous items, and layout that allows family members to reach him quickly when seizures occur.
EEG Monitoring: Periodic EEG testing helps his medical team assess his brain activity patterns, evaluate medication effectiveness, and adjust treatment. These tests may occur in hospital settings or through ambulatory EEG devices he wears at home to capture seizure activity in his natural environment.
Seizure Tracking and Documentation: His family maintains detailed logs of seizure activity—types, duration, time of day, potential triggers, recovery time, and any injuries or complications. This documentation proves invaluable during medical appointments, allowing providers to see patterns and make informed treatment decisions rather than relying on family's imperfect memory of weeks or months of seizure activity.
Representation Notes (Meta-Canon)¶
Authenticity Guidelines: - Portray LGS as profoundly serious and life-impacting without making it the only thing about Minjae - Show multiple seizure types with accurate physical presentation and aftermath - Depict treatment as challenging and imperfect, not a simple matter of "taking medication" - Demonstrate how LGS intersects with his other conditions in complex ways - Show family adaptation and coping without portraying them as saints or martyrs - Include moments of joy, connection, and normalcy alongside medical challenges - Avoid inspiration porn or miracle cure narratives - Depict his personhood as primary, his conditions as context
Research Base: - Medical information drawn from current understanding of Lennox-Gastaut Syndrome - Seizure presentations based on documented LGS manifestations - Treatment approaches reflect current standard of care with realistic efficacy limits - Safety protocols and equipment based on actual recommendations for severe epilepsy management - Family experiences reflect patterns documented in caregiver literature and disability community narratives
Boundaries: - Do not graphically describe seizures in ways that sensationalize or exploit - Avoid framing seizures as punishment or cosmic judgment - Do not suggest that positive thinking, dietary changes, or alternative treatments could cure or significantly improve LGS - Resist narratives where his epilepsy makes him mystical, prophetic, or supernaturally gifted - Don't use seizures as plot devices to create artificial drama—they are medical reality, not narrative convenience
Sensitivity Considerations: - Remember that readers may have epilepsy or care for people with seizure disorders - Depict medical trauma realistically without being gratuitously triggering - Show agency and autonomy even within significant medical constraint - Portray family caregiving as love in action, not burden or sacrifice - Include disabled community support and peer relationships - Show how ableism and inadequate medical systems compound individual medical conditions
Related Entries¶
Related Entries: Minjae Lee; Caleb Ross; Cerebral Palsy Reference; POTS Reference; Autism Spectrum - Series Reference; Gastroparesis Reference; Chronic Fatigue Syndrome Reference; Johns Hopkins School of Medicine; Rome International Piano Competition; Nari Lee; Joon-Ho Lee